Literature DB >> 20436762

Comorbid adolescent substance use and major depressive disorders: a review.

Yifrah Kaminer1, Daniel F Connor, John F Curry.   

Abstract

Psychiatric comorbidity is the rule rather than the exception in adolescents diagnosed with substance use disorders (SUD). The aim of this evidence-based review is to enhance practitioners' understanding of the relationship between the commonly concomitant SUD and comorbid unipolar depression as well as increase the knowledge of treatment of adolescents with these comorbid disorders.

Entities:  

Keywords:  adolescent substance use disorders; depression; treatment

Year:  2007        PMID: 20436762      PMCID: PMC2861513     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  56 in total

1.  Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients?

Authors:  B L Halpern-Felsher; E M Ozer; S G Millstein; C J Wibbelsman; C D Fuster; A B Elster; C E Irwin
Journal:  Arch Pediatr Adolesc Med       Date:  2000-02

Review 2.  The natural history of adolescent alcohol use disorders.

Authors:  Duncan B Clark
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

3.  The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers.

Authors:  K C Winters; R D Stinchfield; E Opland; C Weller; W W Latimer
Journal:  Addiction       Date:  2000-04       Impact factor: 6.526

4.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.

Authors:  D A Brent; D Holder; D Kolko; B Birmaher; M Baugher; C Roth; S Iyengar; B A Johnson
Journal:  Arch Gen Psychiatry       Date:  1997-09

5.  Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions.

Authors:  G N Clarke; P Rohde; P M Lewinsohn; H Hops; J R Seeley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-03       Impact factor: 8.829

Review 6.  Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.

Authors:  Jack R Cornelius; Duncan B Clark; Oscar G Bukstein; Boris Birmaher; Ihsan M Salloum; Sandra A Brown
Journal:  Addict Behav       Date:  2005-08-15       Impact factor: 3.913

7.  A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.

Authors:  Paula D Riggs; Susan K Mikulich-Gilbertson; Robert D Davies; Michelle Lohman; Constance Klein; Shannon K Stover
Journal:  Arch Pediatr Adolesc Med       Date:  2007-11

8.  Psychotherapies for adolescent substance abusers: a pilot study.

Authors:  Y Kaminer; J A Burleson; C Blitz; J Sussman; B J Rounsaville
Journal:  J Nerv Ment Dis       Date:  1998-11       Impact factor: 2.254

9.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

10.  Depression in substance-dependent delinquents.

Authors:  P D Riggs; S Baker; S K Mikulich; S E Young; T J Crowley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-06       Impact factor: 8.829

View more
  13 in total

1.  The effects of mental health symptoms and marijuana expectancies on marijuana use and consequences among at-risk adolescents.

Authors:  Eric R Pedersen; Jeremy N V Miles; Karen Chan Osilla; Brett A Ewing; Sarah B Hunter; Elizabeth J D'Amico
Journal:  J Drug Issues       Date:  2015-04-01

2.  Reductions in anxiety and depression symptoms in youth receiving substance use treatment.

Authors:  Viviana E Horigian; Carl F Weems; Michael S Robbins; Daniel J Feaster; Jessica Ucha; Michael Miller; Robert Werstlein
Journal:  Am J Addict       Date:  2013 Jul-Aug

Review 3.  Youth with substance abuse and comorbid mental health disorders.

Authors:  Christopher A Lamps; Aradhana B Sood; Rishi Sood
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

4.  Treatment of comorbid adolescent cannabis use and major depressive disorder.

Authors:  Yifrah Kaminer; Daniel F Connor; John F Curry
Journal:  Psychiatry (Edgmont)       Date:  2008-09

5.  Cannabis and the Developing Adolescent Brain.

Authors:  Adina S Fischer; Susan F Tapert; Dexter Lee Louie; Alan F Schatzberg; Manpreet K Singh
Journal:  Curr Treat Options Psychiatry       Date:  2020-04-18

6.  Depression with and without Comorbid Substance Dependence in a Child Welfare Sample of Young Adults.

Authors:  Heather Orton Anderson; Anne M Libby
Journal:  Depress Res Treat       Date:  2010-12-09

7.  The association between psychopathology and substance use: adolescent and young adult substance users in inpatient treatment in Cape Town, South Africa.

Authors:  Amina Saban; Alan Flisher; Ria Laubscher; Leslie London; Neo Morojele
Journal:  Pan Afr Med J       Date:  2014-01-18

8.  Text mining for identifying topics in the literatures about adolescent substance use and depression.

Authors:  Shi-Heng Wang; Yijun Ding; Weizhong Zhao; Yung-Hsiang Huang; Roger Perkins; Wen Zou; James J Chen
Journal:  BMC Public Health       Date:  2016-03-19       Impact factor: 3.295

9.  Multiplicative Effects of Social and Psychological Risk Factors on College Students' Suicidal Behaviors.

Authors:  Shervin Assari
Journal:  Brain Sci       Date:  2018-05-17

Review 10.  On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods.

Authors:  C E Strong; Mohamed Kabbaj
Journal:  Neurobiol Stress       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.